Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126236631 | 12623663 | 1 | I | 20160606 | 20160701 | 20160804 | 20160804 | EXP | IT-MINISAL02-365631 | IT-TEVA-674575ACC | TEVA | 92.25 | YR | M | Y | 0.00000 | 20160805 | MD | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126236631 | 12623663 | 1 | PS | ZOLPIDEM TARTRATE. | ZOLPIDEM TARTRATE | 1 | Oral | 1 DOSAGE FORMS DAILY; | U | U | 76410 | 1 | DF | ||||||
126236631 | 12623663 | 2 | SS | TRITTICO - 50 MG COMPRESSE RIVESTITE CON FILM | TRAZODONE HYDROCHLORIDE | 1 | Oral | DAILY | U | U | 0 | ||||||||
126236631 | 12623663 | 3 | C | CARDIRENE - 75 MG POLVERE PER SOLUZIONE ORALE | ASPIRIN DL-LYSINE | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 4 | C | SELG - POLVERE PER SOLUZIONE ORALE | 2 | U | 0 | ||||||||||||
126236631 | 12623663 | 5 | C | LUVION - 50 MG COMPRESSE | 2 | U | 0 | ||||||||||||
126236631 | 12623663 | 6 | C | MINITRAN - 5 MG/24 ORE CEROTTI TRANSDERMICI | 2 | U | 0 | ||||||||||||
126236631 | 12623663 | 7 | C | COUMADIN | WARFARIN SODIUM | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 8 | C | CLEXANE - 2000 U.I. AXA/0,2 ML SOLUZIONE INIETTABILE | 2 | U | 0 | ||||||||||||
126236631 | 12623663 | 9 | C | DIBASE - 10.000 UI/ML GOCCE ORALI SOLUZIONE | 2 | U | 0 | ||||||||||||
126236631 | 12623663 | 10 | C | CALCIUM CARBONATE. | CALCIUM CARBONATE | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 11 | C | FUROSEMIDE. | FUROSEMIDE | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 12 | C | RAMIPRIL. | RAMIPRIL | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 13 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 14 | C | FINASTERIDE. | FINASTERIDE | 1 | U | 0 | |||||||||||
126236631 | 12623663 | 15 | C | BISOPROLOL HEMIFUMARATE | BISOPROLOL FUMARATE | 1 | U | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126236631 | 12623663 | 1 | Product used for unknown indication |
126236631 | 12623663 | 2 | Product used for unknown indication |
126236631 | 12623663 | 3 | Product used for unknown indication |
126236631 | 12623663 | 4 | Product used for unknown indication |
126236631 | 12623663 | 5 | Product used for unknown indication |
126236631 | 12623663 | 6 | Product used for unknown indication |
126236631 | 12623663 | 7 | Product used for unknown indication |
126236631 | 12623663 | 8 | Product used for unknown indication |
126236631 | 12623663 | 9 | Product used for unknown indication |
126236631 | 12623663 | 10 | Product used for unknown indication |
126236631 | 12623663 | 11 | Product used for unknown indication |
126236631 | 12623663 | 12 | Product used for unknown indication |
126236631 | 12623663 | 13 | Product used for unknown indication |
126236631 | 12623663 | 14 | Product used for unknown indication |
126236631 | 12623663 | 15 | Product used for unknown indication |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126236631 | 12623663 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126236631 | 12623663 | Confusional state | |
126236631 | 12623663 | Dysarthria | |
126236631 | 12623663 | Sopor |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126236631 | 12623663 | 1 | 20160101 | 20160628 | 0 | |
126236631 | 12623663 | 2 | 20160101 | 20160606 | 0 |